| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Zhao-You Tang | |
| Hui-Chuan Sun | |||
| P2860 | cites work | Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years | Q74072065 |
| Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma | Q74130358 | ||
| Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial | Q74250283 | ||
| Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma | Q77215000 | ||
| Progress and prospects in hepatocellular carcinoma surgery | Q77346466 | ||
| Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma | Q77554346 | ||
| Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis | Q78044194 | ||
| Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial | Q33871980 | ||
| Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial | Q33920539 | ||
| Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise | Q33938840 | ||
| Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities | Q34132119 | ||
| Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials | Q34186952 | ||
| Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma | Q34384937 | ||
| Non-surgical treatment of hepatocellular carcinoma | Q34539241 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. | Q34714683 | ||
| Adopted immunochemotherapy using IL-2 and spleen LAK cell--randomized study | Q40745672 | ||
| Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials | Q40827604 | ||
| Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials | Q43645553 | ||
| Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy | Q43949008 | ||
| Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma | Q44759503 | ||
| Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy | Q45732900 | ||
| Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial | Q45737388 | ||
| Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer | Q45741344 | ||
| Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. | Q45749869 | ||
| Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. | Q53392703 | ||
| Adoptive immunotherapy for cancer. | Q54324804 | ||
| A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. | Q55176367 | ||
| Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group | Q71073938 | ||
| Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study | Q71694997 | ||
| Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype | Q71858038 | ||
| Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC) | Q71925986 | ||
| Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma | Q72094162 | ||
| Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin alone | Q72230770 | ||
| Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal | Q72609881 | ||
| Metachronous multicentric occurrence of hepatocellular carcinoma after surgical treatment - clinicopathological comparison with recurrence due to metastasis | Q73088134 | ||
| Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study | Q73340869 | ||
| Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach | Q73979679 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | randomized controlled trial | Q1436668 |
| P304 | page(s) | 635-640 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials | |
| P478 | volume | 9 |
| Q58329162 | A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach |
| Q35611503 | A decade's studies on metastasis of hepatocellular carcinoma |
| Q36934253 | A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma |
| Q42002394 | A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma. |
| Q38620322 | Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. |
| Q36308295 | Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. |
| Q34586952 | Association between the presence of H pylori in the liver and hepatocellular carcinoma: a meta-analysis |
| Q40462976 | Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells. |
| Q36213803 | Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis |
| Q33868814 | Helicobacter infection in hepatocellular carcinoma tissue |
| Q43083274 | Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma |
| Q37288364 | Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy |
| Q81544297 | Hepatocellular carcinoma: current treatment strategies |
| Q35739058 | Hepatocellular carcinoma: epidemic and treatment |
| Q50236833 | High expression of Parkin predicts easier recurrence of patients with adjuvant transarterial chemoembolization |
| Q36373254 | Immunological treatment of liver tumors |
| Q36178081 | Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. |
| Q45720793 | Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection |
| Q45492170 | Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma |
| Q96837421 | MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Trans-Arterial Chemoembolization Resistance in Hepatocellular Carcinoma |
| Q53296852 | Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection. |
| Q36700251 | Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions |
| Q45412652 | P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. |
| Q36065568 | Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study |
| Q46396394 | Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion |
| Q40347323 | Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis. |
| Q38203306 | Postoperative therapy options for hepatocellular carcinoma |
| Q84598404 | Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge |
| Q51775986 | Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. |
| Q38445388 | Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm. |
| Q45745392 | Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. |
| Q37058807 | The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus |
| Q49491370 | The status of transarterial chemoembolization treatment in the era of precision oncology |
| Q34642418 | Transcatheter arterial chemoembolization: history for more than 30 years. |
| Q35739061 | Treatment of hepatocarcinoma |
Search more.